The "Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering.

PDS Biotechnology ( ($PDSB) ) just unveiled an update. On November 11, 2025, PDS Biotechnology Corporation announced a securities purchase ...

China's antitrust regulator approved conditions for a joint venture between Chilean companies Codelco and SQM to produce ...

The legal agreement, if approved by a federal court, could end two decades of litigation between the two biggest U.S. card ...

ADDRI-sponsored trial in Australia planned to enroll approximately 50 patients, led by A/Prof Steven Kao and Dr Melvin Chin; part of Cyncado’s international program for mesothelioma ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the ...

November 12, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ('Inventiva' or the 'Company'), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment ...

AlphaTON Capital (ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, operating as Cyncado Therapeutics, announced a ...

The sanctions freeze Iranian assets abroad, halt arms deals with Tehran, and penalize any development of Iran’s ballistic ...

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on Company's prior Phase 2 success BiomX expects FDA feedback on BX004 clinica ...